Testavan®
Testavan® is a 2% transdermal testosterone gel and is indicated for the treatment of adult male hypogonadism.[1]
Treatment with Testavan® restores testosterone levels to within the normal range and provides sustained improvements in sexual function, QoL and fatigue while demonstrating a favourable safety and tolerability profiles. [1-4]


Improved sexual function
Patients experienced improvements in sexual desire, sexual satisfaction and erectile dysfunction with Testavan®.
Read more

Improved symptoms of fatigue
Testavan® demonstrates improvement in fatigue at 3 and 9 months.
Read more

Improved overall QoL
Testavan® offers significant improvements in mental and physical health.
Read more
.png)
Favourable safety and tolerability profile
Testavan® offers a well-tolerated safety profile and favorable tolerability profile with low incidence of elevated PSA.
Read more
References
1. Testavan® Summary of Product Characteristics. Available from : https://www.medicines.org.uk/emc/product/13936/smpc . Last accessed : August 2022.
2. Olsson H et al. Clin Pharmacol Drug Dev 2014;3(5):358–364.
3. Arver S et al. Andrology 2018;6(3):396–407.
4. Cunningham G et al. Endocr Pract 2017;23(5):557–565.
QoL = quality of life.